Press Releases
Oregon Primary Care Association Partners with RxParadigm to Launch Neutral 340B Claims Clearinghouse
CLAYMONT, DE, UNITED STATES, March 28, 2025 — The Oregon Primary Care Association (OPCA) is pleased to announce its partnership with RxParadigm to implement a neutral 340B claims clearinghouse powered by the Tungsten+PLUS™ platform. This first-of-its-kind collaboration in Oregon is designed to enhance accountability and ensure long-term 340B program compliance and transparency for all stakeholders.
The introduction of this neutral clearinghouse builds upon Oregon’s already successful retrospective Medicaid rebate claims review program. By joining RxParadigm’s clearinghouse, Oregon is taking a comprehensive approach to strengthening program integrity and operational efficiency—ensuring that legislators, pharmacy benefit managers (PBMs), insurance plans, and drug manufacturers can trust the accuracy of Federally Qualified Health Centers 340B program operations in Oregon. This initiative also addresses longstanding concerns such as duplicate payments, which have led to legislative and legal challenges.
Infinity Health Partners with RxParadigm to Drive Transparency in the 340B Program
CLAYMONT, DE, UNITED STATES, February 28, 2025 — Kyle Ahlenstorf, CEO of Infinity Health, is proud to announce a strategic partnership with RxParadigm, Inc., a leading provider of 340B program and pharmacy supply chain solutions. This partnership marks the adoption of the Tungsten + PLUS™ platform, a neutral 340B clearinghouse solution designed to enhance transparency, prevent duplicate discounts, and help health centers navigate the complexities of the 340B program more effectively.
Health centers across the country are increasingly looking for ways to lead the charge in creating transparency within the 340B program. As one of the largest safety-net programs in the U.S., 340B allows eligible health centers to access discounted medications, supporting their ability to serve underserved populations. However, navigating this program has become more complex, with concerns about duplicate discounting and restrictive contract pharmacy limitations. By adopting the Tungsten+ PLUS™ platform, Infinity Health aims to address these issues and ensure compliance with both state and federal regulations.
RxParadigm Partners with Rhode Island Health Center Association to Strengthen 340B Program Compliance
CLAYMONT, DE, UNITED STATES, February 4, 2025 — RxParadigm, Inc., a leader in providing technology solutions to the 340B program is proud to announce its partnership with the Rhode Island Health Center Association (RIHCA), and the eight community health centers RIHCA supports. This collaboration provides RIHCA members with exclusive access to Tungsten + PLUS™, a cutting-edge 340B clearinghouse platform designed to streamline compliance, resolve duplicate discount challenges, and ensure adherence to state and federal regulations.
The 340B program plays a critical role in improving patient affordability by offering significant medication discounts to eligible health centers.
Partnership Enhances Transparency and Addresses Duplicate Discount Challenges for Virginia’s Community Health Centers
CLAYMONT, DE, UNITED STATES, November 27, 2024 — RxParadigm, Inc., a leader in 340B program and pharmacy supply chain solutions, is pleased to announce a partnership with the Virginia Community Healthcare Association (VCHA). This collaboration will provide VCHA members exclusive access to Tungsten + PLUS™, a neutral 340B clearinghouse platform that simplifies program compliance, manages duplicate discount issues, and ensures adherence to both state and federal regulations.
The 340B program offers critical medication discounts to eligible health centers, improving affordability for patients. However, the program’s complexity—particularly the interactions among Covered Entities, drug manufacturers, Medicaid offices, and health plans—has created challenges, including manufacturer-imposed restrictions on contract pharmacies, impacting health centers across Virginia and the nation.
RxParadigm Partners with PrairieStar Health Center to Launch Tungsten + PLUS™: A Neutral 340B Clearinghouse Solution
New Partnership Brings Transparency, Resolves Duplicate Discount Challenges for PrairieStar Health Center, and Health Centers Nationwide
CLAYMONT, DE, UNITED STATES, November 14, 2024 — RxParadigm, Inc., a leader in 340B program and pharmacy supply chain solutions, has announced a strategic partnership with PrairieStar Health Center to launch Tungsten + PLUS™, a neutral 340B clearinghouse platform. This innovative solution is designed to certify 340B claims, prevent duplicate discounts, and ensure compliance with state and federal regulations.
With this collaboration, PrairieStar Health Center becomes a trailblazer as one of the first health centers to adopt a neutral clearinghouse solution, setting a nationwide precedent for transparency in 340B program management. The 340B program is critical for health centers, enabling access to discounted medications for underserved populations. However, managing relationships between Covered Entities, drug manufacturers, Medicaid, and health plans poses unique challenges—particularly concerning duplicate discounts that lead to contract pharmacy restrictions impacting centers across the U.S.